Frankfurt
17.03.25 | 08:52
3,000 Euro
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | OPTHEA LIMITED: Long Term Suspended Entities | 2 | ASX | ||
| 15.01. | OPTHEA LIMITED: Notification of cessation of securities - OPT | 2 | ASX | ||
| 22.12.25 | OPTHEA LIMITED: Change of Director's Interest Notice - KC & LG | - | ASX | ||
| 19.12.25 | OPTHEA LIMITED: Notification regarding unquoted securities - OPT | 1 | ASX | ||
| 17.12.25 | Health Check: No longer sheepish, Opthea flags fresh start | 3 | Stockhead | ||
| OPTHEA LIMITED ADR Aktie jetzt für 0€ handeln | |||||
| 17.12.25 | OPTHEA LIMITED: Investor Update Presentation | 1 | ASX | ||
| 11.12.25 | OPTHEA LIMITED: Notice of Market Update | 16 | ASX | ||
| 07.12.25 | OPTHEA LIMITED: Change in substantial holding | - | ASX | ||
| 20.11.25 | OPTHEA LIMITED: Voluntary delisting from Nasdaq takes effect | 1 | ASX | ||
| 20.11.25 | Opthea Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 12.11.25 | Opthea Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 11.11.25 | OPTHEA LIMITED: Results of AGM | 1 | ASX | ||
| 10.11.25 | Opthea Ltd - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | - | SEC Filings | ||
| 30.10.25 | OPTHEA LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report | - | ASX | ||
| 30.10.25 | Opthea Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 29.10.25 | OPTHEA LIMITED: Opthea announces intention to delist from Nasdaq | - | ASX | ||
| 27.10.25 | Opthea Appoints Hamish George As CFO | - | RTTNews | ||
| 26.10.25 | OPTHEA LIMITED: Appointment of Company Secretary and CFO | 1 | ASX | ||
| 15.10.25 | OPTHEA LIMITED: Long Term Suspended Entities | 1 | ASX | ||
| 09.10.25 | OPTHEA LIMITED: Notice of Annual General Meeting/Proxy Form | - | ASX |
1 2 Weiter >>
39 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CORE ONE LABS | - | - | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 22.09.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 22.09.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 22.09.2025ISIN NameAU000000PEK2 PEAK... ► Artikel lesen | |
| PALATIN TECHNOLOGIES | 15,600 | 0,00 % | Palatin Technologies, Inc.: Palatin Reports First Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update | Significant progress on multiple fronts - obesity pipeline advancing towards the clinic, out-licensing collaboration, strengthened balance sheet, and reinstatement... ► Artikel lesen | |
| COSCIENS BIOPHARMA | 1,620 | 0,00 % | COSCIENS Biopharma Inc. Announces Leadership Change | TORONTO, ONTARIO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) ("COSCIENS" or the "Company"), a life science company focused on natural ingredients and pharmaceutical... ► Artikel lesen | |
| HALOZYME THERAPEUTICS | 59,02 | +0,37 % | Halozyme Therapeutics: A 6.3 Rating and a Future Full of Uncertainty | ||
| ABCELLERA BIOLOGICS | 3,434 | -1,32 % | AbCellera Biologics Inc. - 8-K, Current Report | ||
| GLOW LIFETECH | 0,028 | 0,00 % | Glow Lifetech Corp.: Glow Lifetech Expands into Medical Cannabis Channel with National Launch on Mendo Medical | Toronto, Ontario--(Newsfile Corp. - January 7, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce the launch of its MOD and .decimal... ► Artikel lesen | |
| BIO-RAD LABORATORIES | 252,30 | +0,12 % | Here's Why You Should Hold Bio-Rad Stock in Your Portfolio Now | ||
| AVID BIOSERVICES | 12,100 | 0,00 % | Avid Bioservices Appoints Rich McAvoy as Chief Business Officer | Seasoned business and finance leader brings disciplined growth mindset to support Avid's next phase of expansion and client executionTUSTIN, Calif., Jan. 15, 2026 /PRNewswire/ -- Avid Bioservices... ► Artikel lesen | |
| BIOLINERX | 2,345 | -0,64 % | BioLineRx Ltd. - S-8, Securities to be offered to employees in employee benefit plans | ||
| WHITEHAWK THERAPEUTICS | 2,200 | 0,00 % | Whitehawk Therapeutics, Inc.: Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer | Dr. Dugan brings extensive clinical development leadership to Whitehawk as ADC programs near the clinic
MORRISTOWN, N.J., Dec. 1, 2025 /PRNewswire/ -- Whitehawk... ► Artikel lesen | |
| MINERVA NEUROSCIENCES | 3,360 | -2,89 % | Minerva Neurosciences, Inc: Minerva Neurosciences to Host Virtual KOL Event to Discuss Roluperidone: From Unmet Need to Reality - Potentially the First Treatment for Patients with Negative Symptoms of Schizophrenia, on February 3, 2026 | BURLINGTON, Mass., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous... ► Artikel lesen | |
| APPLIED THERAPEUTICS | 0,081 | -1,35 % | Cycle Pharmaceuticals to Acquire Applied Therapeutics | NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT; "Applied"), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for rare... ► Artikel lesen | |
| OVID THERAPEUTICS | 1,440 | -2,04 % | Ovid Therapeutics Inc.: Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical Officer | NEW YORK, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company developing small molecule medicines for brain disorders with significant unmet need,... ► Artikel lesen | |
| GEOVAX LABS | 2,950 | 0,00 % | EQS-News: GeoVax Labs, Inc.: GeoVax Announces 1-for-25 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement | GeoVax, Inc. / Key word(s): Financial
GeoVax Announces 1-for-25 Reverse Stock Split to Regain Compliance With Nasdaq Minimum Bid Requirement
08.01.2026 / 15:03 CET/CEST
The issuer is solely responsible... ► Artikel lesen | |
| COCRYSTAL | 0,895 | +1,70 % | Cocrystal Pharma, Inc.: Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus | Subject enrollment expected to begin in Q1 2026CDI-988 is the first oral broad-spectrum antiviral drug candidate for potential prevention of norovirus outbreaks and treatment of acute viral gastroenteritis... ► Artikel lesen |
OPTHEA LIMITED ADR gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 3,000 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu OPTHEA LIMITED ADR finden Sie auf Wallstreet Online.